Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment

Fig. 4

The effects of vitamin C, MitoQ, or SKQ1 on cell viability against Dox when given as co-treatment. The representative pictures of cells (100 X) after co-treatment are shown in A (scale bar: 50 μm). The effects of different antioxidants on Dox-induced cell damage are illustrated in B. MitoQ and SKQ1, but not vitamin C, significantly increased cell viability in the presence of Dox. *p < 0.05; **p < 0.01 vs Dox

Back to article page